| Patrick Cassell, MD | |
|
246 Pleasant St, Suite 103, Concord, NH 03301-2548 | |
| (603) 224-6070 | |
| (603) 224-6994 |
| Full Name | Patrick Cassell |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 246 Pleasant St, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013945252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 7759 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Cassell, MD 246 Pleasant St, Suite 103, Concord, NH 03301-2548 Ph: (603) 224-6070 | Patrick Cassell, MD 246 Pleasant St, Suite 103, Concord, NH 03301-2548 Ph: (603) 224-6070 |
News Archive
The National Cancer Institute has renewed the designation of Huntsman Cancer Institute at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization.
Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.
An analysis of nearly 200 independent studies involving more than 230,000 adult participants finds that having been sexually assaulted is associated with significantly increased risk of anxiety, depression, suicidality, post-traumatic stress disorder, substance abuse, obsessive-compulsive disorder and bipolar disorder.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Using nanoparticles to engineer a special drug, a team of researchers has demonstrated in mice a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies.
› Verified 1 days ago
Dr. Michael A Ferguson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Clayton Theron Jones, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. David Scott Johnson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Primary Care, Concord, NH 03301 Phone: 603-226-2200 | |
Frederick M Briccetti, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant Street, New Hampshire Oncology Hematology Pa, Concord, NH 03301 Phone: 603-224-2556 Fax: 603-226-5821 | |
Dr. Patrick Magnus, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Celia Ann Englander, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 281 N State St, Concord, NH 03301 Phone: 603-271-6064 |